Hypertrophic cardiomyopathy, surprisingly, can be a cause of sudden cardiac death

Runners, often young and seemingly healthy-die suddenly during or, after marathons. The frequent sudden death events in marathons make headlines and strike fear in the hearts of the runners who read them.

However, it’s unreasonable to blame cardiac arrest or sudden death for marathons. According to the latest American Heart Association statistics, sudden cardiac arrest isn't common among runners—about 0.54 per 100,000, which means that only 1 out of approximately 185,000 marathon runners is likely to die suddenly (1 in 185,000).

More studies have revealed the truth about cardiac arrest during long-distance running races. A research assessed the incidence and outcomes of cardiac arrest associated with marathon and half-marathon races in the U.S. from year 2000 to 2010. Of 10.9 million runners, 59 had cardiac arrest, and 42 were fatal. The study concluded that younger persons who have cardiac arrest are most commonly attributable to hypertrophic cardiomyopathy, and resuscitation in cases of hypertrophic cardiomyopathy is reportedly less successful than in other conditions. 

[Source: Kim J H, Malhotra R, Chiampas G, et al.Cardiac arrest during long-distance running races[J].New England Journal of Medicine, 2012, 366(2): 130-140.]

Venus Medtech provides an innovative solution to hypertrophic cardiomyopathy (HCM), the Liwen RF™ Ablation System, which pioneers the treatment of HCM with ultrasound-guided percutaneous intramyocardial septal radiofrequency ablation and presents a safe, effective, precise, minimally invasive and innovative option. The Liwen RF™ ablation system has the advantages of minimally invasive approach, percutaneous myocardial puncture, less trauma, better efficacy, lower risk, and faster recovery. 

*This information does not constitute professional medical or legal advice, and Venus makes no representation or warranty regarding this information or its completeness accuracy or timeliness.

#HCM# hypertrophic cardiomyopathy#structural heart#Liwen RF#Liwen procedure#SCD#mavacamten#radiofrequency ablation# mavacamten#